NEW YORK (GenomeWeb News) – Under a new strategic partnership, TrimGen will develop technology for Spartan Bioscience and Spartan will distribute TrimGen products in Canada, Ottawa-based Spartan said today.
 
TrimGen has agreed to develop real-time PCR reagents and kits for the Spartan DX device. Coupling the Spartan DX with TrimGen’s real-time PCR assays allows Spartan to offer “a complete solution for rapid DNA testing,” Spartan Bioscience CEO Paul Lem said in a statement.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.